Open AccessCerebrolysin in Mild-to-Moderate Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Clinical Trials
Author(s) -
Serge Gauthier,
Jefferson V. Proaño,
Jianping Jia,
Lutz Froelich,
Johannes Vester,
Edith Doppler
Publication year - 2015
Publication title -
dementia and geriatric cognitive disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.026
H-Index - 110
eISSN - 1421-9824
pISSN - 1420-8008
DOI - 10.1159/000377672
Subject(s) - cerebrolysin , placebo , randomized controlled trial , meta analysis , medicine , clinical trial , dementia , odds ratio , alzheimer's disease , psychology , disease , pathology , alternative medicine
The aim of this study was to provide a systematic and quantitative summary of benefit and risk of Cerebrolysin in patients with mild-to-moderate Alzheimer's disease (AD) and to avoid major deficiencies of an earlier meta-analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom